Wikipedia:WikiProject Medicine/Cochrane/Cochrane Review List/Brain Nerves and Mind

  Cochrane Brain, Nerves and Mind Network: Reviews to be considered for Wikipedia Review Lists Updated: April 3 2020

Common Mental Disorders Group
Updated: Aug 1 2023

✅ 2023-7 Brexpiprazole versus placebo or other antidepressive agents for treating depression PMID undefined https://doi.org/10.1002/14651858.CD013866.pub2

✅ 2022-5 Community-based interventions for improving mental health in refugee children and adolescents in high-income countries PMID 35532139 https://doi.org/10.1002/14651858.CD013657.pub2

✅ 2022-2 Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD) PMID undefined https://doi.org/10.1002/14651858.CD013443.pub2

2021-12 Pre-deployment programmes for building resilience in military and frontline emergency service personnel PMID undefined https://doi.org/10.1002/14651858.CD013242.pub2

✅ 2021-12 Mindfulness-based psychological interventions for improving mental well-being in medical students and junior doctors PMID undefined https://doi.org/10.1002/14651858.CD013740.pub2

✅ 2021-9 Behavioural and cognitive behavioural therapy for obsessive compulsive disorder (OCD) in individuals with autism spectrum disorder (ASD) PMID undefined https://doi.org/10.1002/14651858.CD013173.pub2

✅ 2021-6 Magnetic seizure therapy for treatment-resistant depression PMID undefined https://doi.org/10.1002/14651858.CD013528.pub2

2021-5 Prognostic models for predicting relapse or recurrence of major depressive disorder in adults PMID undefined https://doi.org/10.1002/14651858.CD013491.pub2

2021-4 Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults PMID undefined https://doi.org/10.1002/14651858.CD013495.pub2

2021-4 Psychosocial interventions for self-harm in adults PMID undefined https://doi.org/10.1002/14651858.CD013668.pub2

2021-1 Pharmacological interventions for self-harm in adults PMID undefined https://doi.org/10.1002/14651858.CD013669.pub2

✅ 2020-11 Cognitive behavioural therapy for anxiety disorders in children and adolescents PMID undefined https://doi.org/10.1002/14651858.CD013162.pub2

2020-9 Means restriction for the prevention of suicide on roads PMID undefined https://doi.org/10.1002/14651858.CD013738

2020-8 Behavioural activation therapy for depression in adults with non-communicable diseases PMID undefined https://doi.org/10.1002/14651858.CD013461.pub2

✅ 2020-7 Behavioural activation therapy for depression in adults PMID undefined https://doi.org/10.1002/14651858.CD013305.pub2

2019-12 Pharmacy-based management for depression in adults PMID 31868236 https://doi.org/10.1002/14651858.CD013299.pub2

2019-11 Present-centered therapy (PCT) for post-traumatic stress disorder (PTSD) in adults PMID 31742672 https://doi.org/10.1002/14651858.CD012898.pub2

2019-5 Family therapy approaches for anorexia nervosa PMID 31041816 https://doi.org/10.1002/14651858.CD004780.pub4

2019-3 Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease PMID 30838649 https://doi.org/10.1002/14651858.CD012347.pub2

2018-12 Psychological therapies for anxiety and depression in children and adolescents with long-term physical conditions PMID 30578633 https://doi.org/10.1002/14651858.CD012488.pub2

2018-12 Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease PMID 30566235 https://doi.org/10.1002/14651858.CD012346.pub2

2018-8 E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions PMID 30110718 https://doi.org/10.1002/14651858.CD012489.pub2

2018-8 Client feedback in psychological therapy for children and adolescents with mental health problems PMID 30124233 https://doi.org/10.1002/14651858.CD011729.pub2

2018-7 Psychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crises PMID 29975811 https://doi.org/10.1002/14651858.CD011849.pub2

2018-6 Couple therapy for depression PMID 29882960 https://doi.org/10.1002/14651858.CD004188.pub3

2017-3 Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 28322440 https://doi.org/10.1002/14651858.CD010673.pub2

2016-10 Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults PMID 27730622 https://doi.org/10.1002/14651858.CD011170.pub2

2016-7 Routine use of patient reported outcome measures (PROMs) for improving treatment of common mental health disorders in adults PMID 27409972 https://doi.org/10.1002/14651858.CD011119.pub2

2016-5 Psychosocial interventions for self-harm in adults PMID 27168519 https://doi.org/10.1002/14651858.CD012189

2016-4 Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder PMID 27040448 https://doi.org/10.1002/14651858.CD010204.pub2

2015-7 Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa PMID 26212713 https://doi.org/10.1002/14651858.CD003909.pub2

2015-4 Debriefing interventions for the prevention of psychological trauma in women following childbirth PMID 25858181 https://doi.org/10.1002/14651858.CD007194.pub2

2015-1 Pharmacotherapy for anxiety and comorbid alcohol use disorders PMID 25601826 https://doi.org/10.1002/14651858.CD007505.pub2

2014-11 Psychological, social and welfare interventions for psychological health and well-being of torture survivors PMID 25386846 https://doi.org/10.1002/14651858.CD009317.pub2

2014-10 Interventions for primary prevention of suicide in university and other post-secondary educational settings PMID 25353703 https://doi.org/10.1002/14651858.CD009439.pub2

2014-9 Antidepressant treatment for postnatal depression PMID 25211400 https://doi.org/10.1002/14651858.CD002018.pub2

2013-10 Enhanced care by generalists for functional somatic symptoms and disorders in primary care PMID 24142886 https://doi.org/10.1002/14651858.CD008142.pub2

2013-10 Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder PMID 24132760 https://doi.org/10.1002/14651858.CD003196.pub2

2013-6 Tricyclic drugs for depression in children and adolescents PMID 23780719 https://doi.org/10.1002/14651858.CD002317.pub2

2012-12 Interventions to facilitate return to work in adults with adjustment disorders PMID 23235630 https://doi.org/10.1002/14651858.CD006389.pub2

2012-12 Tiagabine for acute affective episodes in bipolar disorder PMID 23235614 https://doi.org/10.1002/14651858.CD004694.pub3

2012-11 Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents PMID 23152246 https://doi.org/10.1002/14651858.CD007504.pub2

2011-12 Tiagabine in the maintenance treatment of bipolar disorder PMID 22161389 https://doi.org/10.1002/14651858.CD005173.pub3

2011-11 Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease PMID 22071851 https://doi.org/10.1002/14651858.CD008483.pub2

Dementia and Cognitive Improvement Group
Updated: Aug 1 2023

2023-7 Interventions for preventing and reducing the use of physical restraints for older people in all long-term care settings PMID undefined https://doi.org/10.1002/14651858.CD007546.pub3

2023-6 Multi-domain prognostic models used in middle-aged adults without known cognitive impairment for predicting subsequent dementia PMID undefined https://doi.org/10.1002/14651858.CD014885.pub2

✅ 2023-6 Cognitive rehabilitation for people with mild to moderate dementia PMID undefined https://doi.org/10.1002/14651858.CD013388.pub2

2022-4 Algorithm-based pain management for people with dementia in nursing homes PMID undefined https://doi.org/10.1002/14651858.CD013339.pub2

2022-4 Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia PMID undefined https://doi.org/10.1002/14651858.CD013724.pub2

2021-12 Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia PMID undefined https://doi.org/10.1002/14651858.CD013304.pub2

2021-8 Enteral tube feeding for people with severe dementia PMID undefined https://doi.org/10.1002/14651858.CD013503.pub2

2021-7 Diagnostic test accuracy of telehealth assessment for dementia and mild cognitive impairment PMID undefined https://doi.org/10.1002/14651858.CD013786.pub2

✅2021-7 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a general practice (primary care) setting PMID undefined https://doi.org/10.1002/14651858.CD010771.pub3

2021-7 Mini-Cog for the detection of dementia within a primary care setting PMID undefined https://doi.org/10.1002/14651858.CD011415.pub3

✅2021-7 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within community dwelling populations PMID undefined https://doi.org/10.1002/14651858.CD010079.pub3

2021-7 Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting PMID undefined https://doi.org/10.1002/14651858.CD010772.pub3

2021-7 Mini-Cog for the detection of dementia within a secondary care setting PMID undefined https://doi.org/10.1002/14651858.CD011414.pub3

✅2021-7 Montreal Cognitive Assessment for the detection of dementia PMID undefined https://doi.org/10.1002/14651858.CD010775.pub3

✅2021-7 Mini-Cog for the detection of dementia within a community setting PMID undefined https://doi.org/10.1002/14651858.CD010860.pub3

2021-5 Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia PMID undefined https://doi.org/10.1002/14651858.CD004034.pub4

2021-2 Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013306.pub2

2021-2 Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting PMID undefined https://doi.org/10.1002/14651858.CD010945.pub2

2021-2 Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia PMID undefined https://doi.org/10.1002/14651858.CD009081.pub2

2020-12 Souvenaid for Alzheimer's disease PMID undefined https://doi.org/10.1002/14651858.CD011679.pub2

2020-3 Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment PMID undefined https://doi.org/10.1002/14651858.CD009628.pub2

2020-2 Benzodiazepines for treatment of patients with delirium excluding those who are cared for in an intensive care unit PMID undefined https://doi.org/10.1002/14651858.CD012670.pub2

2019-3 Cognitive training for people with mild to moderate dementia PMID 30909318 https://doi.org/10.1002/14651858.CD013069.pub2

2019-3 Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife PMID 30864746 https://doi.org/10.1002/14651858.CD012278.pub2

2019-3 Computerised cognitive training for preventing dementia in people with mild cognitive impairment PMID 30864747 https://doi.org/10.1002/14651858.CD012279.pub2

2018-12 Traditional Chinese herbal medicine for vascular dementia PMID 30520514 https://doi.org/10.1002/14651858.CD010284.pub2

2018-12 Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life PMID 30556597 https://doi.org/10.1002/14651858.CD011906.pub2

2018-11 Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment PMID 30383288 https://doi.org/10.1002/14651858.CD011905.pub2

2018-7 Environmental and behavioural modifications for improving food and fluid intake in people with dementia PMID 30021248 https://doi.org/10.1002/14651858.CD011542.pub2

2018-6 Cholinesterase inhibitors for the treatment of delirium in non-ICU settings PMID 29952000 https://doi.org/10.1002/14651858.CD012494.pub2

2017-11 18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164600 https://doi.org/10.1002/14651858.CD012883

2017-11 18F PET with florbetapir for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164603 https://doi.org/10.1002/14651858.CD012216.pub2

2017-11 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 29164602 https://doi.org/10.1002/14651858.CD012884

2017-6 Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia PMID 28617932 https://doi.org/10.1002/14651858.CD003804.pub2

2017-3 L-carnitine for cognitive enhancement in people without cognitive impairment PMID 28349514 https://doi.org/10.1002/14651858.CD009374.pub3

2016-9 Statin withdrawal in people with dementia PMID 27610945 https://doi.org/10.1002/14651858.CD012050.pub2

2016-1 Statins for the prevention of dementia PMID 26727124 https://doi.org/10.1002/14651858.CD003160.pub3

2015-12 Pharmacotherapy for chronic cognitive impairment in traumatic brain injury PMID 26624881 https://doi.org/10.1002/14651858.CD009221.pub2

2015-9 Rivastigmine for Alzheimer's disease PMID 26393402 https://doi.org/10.1002/14651858.CD001191.pub4

2015-7 Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH) PMID 26222251 https://doi.org/10.1002/14651858.CD010033.pub2

2015-6 Regional Cerebral Blood Flow Single Photon Emission Computed Tomography for detection of Frontotemporal dementia in people with suspected dementia PMID 26102272 https://doi.org/10.1002/14651858.CD010896.pub2

2015-5 Opioids for agitation in dementia PMID 25972091 https://doi.org/10.1002/14651858.CD009705.pub2

2015-3 Cholinesterase inhibitors for rarer dementias associated with neurological conditions PMID 25734590 https://doi.org/10.1002/14651858.CD009444.pub3

2015-1 Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies PMID 25632881 https://doi.org/10.1002/14651858.CD010633.pub2

2014-6 Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) PMID 24913723 https://doi.org/10.1002/14651858.CD008782.pub4

2014-2 Metal protein attenuating compounds for the treatment of Alzheimer's dementia PMID 24563468 https://doi.org/10.1002/14651858.CD005380.pub5

2013-8 Driving assessment for maintaining mobility and safety in drivers with dementia PMID 23990315 https://doi.org/10.1002/14651858.CD006222.pub4

2013-7 Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcohol PMID 23818100 https://doi.org/10.1002/14651858.CD004033.pub3

2013-5 Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus PMID 23728696 https://doi.org/10.1002/14651858.CD009706.pub2

2012-12 Huperzine A for mild cognitive impairment PMID 23235666 https://doi.org/10.1002/14651858.CD008827.pub2

2012-9 Cholinesterase inhibitors for mild cognitive impairment PMID 22972133 https://doi.org/10.1002/14651858.CD009132.pub2

2012-7 Hyperbaric oxygen therapy for vascular dementia PMID 22786527 https://doi.org/10.1002/14651858.CD009425.pub2

2012-6 Omega 3 fatty acid for the prevention of cognitive decline and dementia PMID 22696350 https://doi.org/10.1002/14651858.CD005379.pub3

2012-3 Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease PMID 22419314 https://doi.org/10.1002/14651858.CD006504.pub2

2012-2 Functional analysis-based interventions for challenging behaviour in dementia PMID 22336826 https://doi.org/10.1002/14651858.CD006929.pub2

2011-12 Naftidrofuryl for dementia PMID 22161372 https://doi.org/10.1002/14651858.CD002955.pub4

2011-3 Almitrine-Raubasine combination for dementia PMID 21412915 https://doi.org/10.1002/14651858.CD008068.pub2

Developmental, Psychosocial and Learning Problems Group
Updated: Aug 1 2023

2023-6 Acetylcholinesterase inhibitors for autistic spectrum disorders PMID undefined https://doi.org/10.1002/14651858.CD013851.pub2

2023-6 Comparative effectiveness of psychological interventions for treating the psychological consequences of sexual abuse in children and adolescents: a network meta-analysis PMID undefined https://doi.org/10.1002/14651858.CD013361.pub2

2023-5 Interventions from pregnancy to two years after birth for parents experiencing complex post-traumatic stress disorder and/or with childhood experience of maltreatment PMID undefined https://doi.org/10.1002/14651858.CD014874.pub2

2023-4 Personalised interventions for subgroups of children with conduct problems PMID undefined https://doi.org/10.1002/14651858.CD012746.pub2

2023-2 Behavioural and cognitive-behavioural interventions for outwardly directed aggressive behaviour in people with intellectual disabilities PMID 36745863 https://doi.org/10.1002/14651858.CD003406.pub5

2022-11 Pharmacological interventions for people with borderline personality disorder PMID 36375174 https://doi.org/10.1002/14651858.CD012956.pub2

2022-10 Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis PMID 36194890 https://doi.org/10.1002/14651858.CD013648.pub2

2022-10 Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age PMID 36214650 https://doi.org/10.1002/14651858.CD012717.pub2

2022-9 Crisis interventions for adults with borderline personality disorder PMID 36161394 https://doi.org/10.1002/14651858.CD009353.pub3

2022-9 Overall prognosis of preschool autism spectrum disorder diagnoses PMID 36169177 https://doi.org/10.1002/14651858.CD012749.pub2

2022-8 Memantine for autism spectrum disorder PMID 36006807 https://doi.org/10.1002/14651858.CD013845.pub2

2022-7 Child protection training for professionals to improve reporting of child abuse and neglect PMID 35788913 https://doi.org/10.1002/14651858.CD011775.pub2

2022-6 Non-pharmacological interventions for sleep promotion in hospitalized children PMID 35703367 https://doi.org/10.1002/14651858.CD012908.pub2

2022-4 Fortification of salt with iron and iodine versus fortification of salt with iodine alone for improving iron and iodine status PMID undefined https://doi.org/10.1002/14651858.CD013463.pub2

2022-2 Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults PMID undefined https://doi.org/10.1002/14651858.CD012857.pub2

2021-10 Provision of folic acid for reducing arsenic toxicity in arsenic-exposed children and adults PMID undefined https://doi.org/10.1002/14651858.CD012649.pub2

2021-9 Non-pharmacological interventions for stuttering in children six years and younger PMID undefined https://doi.org/10.1002/14651858.CD013489.pub2

2021-9 Nutrition-specific interventions for preventing and controlling anaemia throughout the life cycle: an overview of systematic reviews PMID undefined https://doi.org/10.1002/14651858.CD013092.pub2

2021-7 Bisphosphonate use in children with cerebral palsy PMID undefined https://doi.org/10.1002/14651858.CD012756.pub2

2021-5 Training healthcare providers to respond to intimate partner violence against women PMID undefined https://doi.org/10.1002/14651858.CD012423.pub2

2021-2 The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder PMID undefined https://doi.org/10.1002/14651858.CD013457.pub2

2020-12 Effects of oral vitamin D supplementation on linear growth and other health outcomes among children under five years of age PMID undefined https://doi.org/10.1002/14651858.CD012875.pub2

2020-11 Mechanically assisted walking training for walking, participation, and quality of life in children with cerebral palsy PMID undefined https://doi.org/10.1002/14651858.CD013114.pub2

2020-7 Psychological interventions to foster resilience in healthcare students PMID undefined https://doi.org/10.1002/14651858.CD013684

2020-6 Cognitive-behavioural therapy (CBT) interventions for young people aged 10 to 18 with harmful sexual behaviour PMID undefined https://doi.org/10.1002/14651858.CD009829.pub2

2020-5 Psychological therapies for people with borderline personality disorder PMID undefined https://doi.org/10.1002/14651858.CD012955.pub2

2020-1 Caregiver involvement in interventions for improving children's dietary intake and physical activity behaviors PMID undefined https://doi.org/10.1002/14651858.CD012547.pub2

2019-12 Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis PMID 31801180 https://doi.org/10.1002/14651858.CD011260.pub2

2019-12 Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis PMID 31858595 https://doi.org/10.1002/14651858.CD011780.pub2

2019-5 Preventive lipid-based nutrient supplements given with complementary foods to infants and young children 6 to 23 months of age for health, nutrition, and developmental outcomes PMID 31046132 https://doi.org/10.1002/14651858.CD012611.pub3

2019-2 Effectiveness of provision of animal-source foods for supporting optimal growth and development in children 6 to 59 months of age PMID 30779870 https://doi.org/10.1002/14651858.CD012818.pub2

2018-11 Community-based supplementary feeding for food insecure, vulnerable and malnourished populations – an overview of systematic reviews PMID 30480324 https://doi.org/10.1002/14651858.CD010578.pub2

2018-10 Parent-mediated interventions for promoting communication and language development in young children with Down syndrome PMID 30321454 https://doi.org/10.1002/14651858.CD012089.pub2

2018-7 Parent-mediated communication interventions for improving the communication skills of preschool children with non-progressive motor disorders PMID 30040119 https://doi.org/10.1002/14651858.CD012507.pub2

2017-11 Point-of-use fortification of foods with micronutrient powders containing iron in children of preschool and school-age PMID 29168569 https://doi.org/10.1002/14651858.CD009666.pub2

2017-5 Family therapy for autism spectrum disorders PMID 28509404 https://doi.org/10.1002/14651858.CD011894.pub2

2017-3 Pharmacological interventions for recurrent abdominal pain in childhood PMID 28262913 https://doi.org/10.1002/14651858.CD010973.pub2

2015-10 Pharmacological interventions for cognitive decline in people with Down syndrome PMID 26513128 https://doi.org/10.1002/14651858.CD011546.pub2

2015-9 Clozapine for psychotic disorders in adults with intellectual disabilities PMID 26397173 https://doi.org/10.1002/14651858.CD010625.pub2

2015-7 Screening women for intimate partner violence in healthcare settings PMID 26200817 https://doi.org/10.1002/14651858.CD007007.pub3

2015-3 Non-speech oral motor treatment for children with developmental speech sound disorders PMID 25805060 https://doi.org/10.1002/14651858.CD009383.pub2

2015-1 Parent-infant psychotherapy for improving parental and infant mental health PMID 25569177 https://doi.org/10.1002/14651858.CD010534.pub2

2014-9 Centre-based day care for children younger than five years of age in low- and middle-income countries PMID 25254354 https://doi.org/10.1002/14651858.CD010543.pub2

2014-9 Centre-based day care for children younger than five years of age in high-income countries PMID 25247266 https://doi.org/10.1002/14651858.CD010544.pub2

2014-4 The WHO Health Promoting School framework for improving the health and well-being of students and their academic achievement PMID 24737131 https://doi.org/10.1002/14651858.CD008958.pub2

2014-3 Auditory-verbal therapy for promoting spoken language development in children with permanent hearing impairments PMID 24619508 https://doi.org/10.1002/14651858.CD010100.pub2

2013-8 Fundoplication versus postoperative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy PMID 23986351 https://doi.org/10.1002/14651858.CD006151.pub3

2013-7 Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused PMID 23904184 https://doi.org/10.1002/14651858.CD008162.pub2

2013-6 Educational and skills-based interventions for preventing relationship and dating violence in adolescents and young adults PMID 23780745 https://doi.org/10.1002/14651858.CD004534.pub3

2013-6 Iron therapy for improving psychomotor development and cognitive function in children under the age of three with iron deficiency anaemia PMID 23744449 https://doi.org/10.1002/14651858.CD001444.pub2

2013-6 Specialist home-based nursing services for children with acute and chronic illnesses PMID 23771694 https://doi.org/10.1002/14651858.CD004383.pub3

2013-4 Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities PMID 23633366 https://doi.org/10.1002/14651858.CD009084.pub2

2012-12 Zinc supplementation for mental and motor development in children PMID 23235652 https://doi.org/10.1002/14651858.CD007991.pub2

2012-10 Interventions for oropharyngeal dysphagia in children with neurological impairment PMID 23076958 https://doi.org/10.1002/14651858.CD009456.pub2

2012-7 Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD) PMID 22786515 https://doi.org/10.1002/14651858.CD008511.pub2

2012-4 Intravenous secretin for autism spectrum disorders (ASD) PMID 22513913 https://doi.org/10.1002/14651858.CD003495.pub3

2012-3 Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents PMID 22419332 https://doi.org/10.1002/14651858.CD008372.pub2

2011-12 Home-based child development interventions for preschool children from socially disadvantaged families PMID 22161419 https://doi.org/10.1002/14651858.CD008131.pub2

2011-12 Intermittent iron supplementation for improving nutrition and development in children under 12 years of age PMID 22161444 https://doi.org/10.1002/14651858.CD009085.pub2

2011-11 Melatonin for non-respiratory sleep disorders in visually impaired children PMID 22071850 https://doi.org/10.1002/14651858.CD008473.pub2

2011-4 Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents PMID 21491402 https://doi.org/10.1002/14651858.CD007839.pub2

2011-3 Individual and group based parenting programmes for improving psychosocial outcomes for teenage parents and their children PMID 21412881 https://doi.org/10.1002/14651858.CD002964.pub2

Drugs and Alcohol Group
Updated: Aug 1 2023

2023-5 Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries PMID undefined https://doi.org/10.1002/14651858.CD013350.pub2

2022-5 Music therapy for people with substance use disorders PMID 35532044 https://doi.org/10.1002/14651858.CD012576.pub3

2021-10 Mindfulness-based interventions for substance use disorders PMID undefined https://doi.org/10.1002/14651858.CD011723.pub2

2021-3 Effectiveness of psychosocial interventions for reducing parental substance misuse PMID undefined https://doi.org/10.1002/14651858.CD012823.pub2

2020-11 Maintenance agonist treatments for opiate-dependent pregnant women PMID undefined https://doi.org/10.1002/14651858.CD006318.pub4

2019-11 Psychological interventions for co-occurring depression and substance use disorders PMID 31769015 https://doi.org/10.1002/14651858.CD009501.pub2

2019-3 Family-based prevention programmes for alcohol use in young people PMID 30888061 https://doi.org/10.1002/14651858.CD012287.pub2

2018-12 Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users PMID 30521696 https://doi.org/10.1002/14651858.CD009269.pub4

2018-12 Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders PMID 30577083 https://doi.org/10.1002/14651858.CD011315.pub2

2017-4 Supervised dosing with a long-acting opioid medication in the management of opioid dependence PMID 28447766 https://doi.org/10.1002/14651858.CD011983.pub2

2016-9 Psychostimulant drugs for cocaine dependence PMID 27670244 https://doi.org/10.1002/14651858.CD007380.pub4

2015-6 Pharmacological interventions for drug-using offenders PMID 26035084 https://doi.org/10.1002/14651858.CD010862.pub2

2015-4 Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions PMID 25835053 https://doi.org/10.1002/14651858.CD006037.pub3

2014-11 Restricting or banning alcohol advertising to reduce alcohol consumption in adults and adolescents PMID 25369459 https://doi.org/10.1002/14651858.CD010704.pub2

2014-6 Maintenance treatments for opiate-dependent adolescents PMID 24957634 https://doi.org/10.1002/14651858.CD007210.pub3

2014-4 Detoxification treatments for opiate dependent adolescents PMID 24777492 https://doi.org/10.1002/14651858.CD006749.pub3

2013-6 QTc interval screening for cardiac risk in methadone treatment of opioid dependence PMID 23787716 https://doi.org/10.1002/14651858.CD008939.pub2

2013-6 Media campaigns for the prevention of illicit drug use in young people PMID 23740538 https://doi.org/10.1002/14651858.CD009287.pub2

2013-6 Magnesium for alcohol withdrawal PMID 23740536 https://doi.org/10.1002/14651858.CD008358.pub2

2013-2 Methadone at tapered doses for the management of opioid withdrawal PMID 23450540 https://doi.org/10.1002/14651858.CD003409.pub4

2013-1 Pharmacological therapies for maintenance treatments of opium dependence PMID 23440817 https://doi.org/10.1002/14651858.CD007775.pub2

2012-12 Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse PMID 23235633 https://doi.org/10.1002/14651858.CD006747.pub2

2011-11 Mentoring adolescents to prevent drug and alcohol use PMID 22071836 https://doi.org/10.1002/14651858.CD007381.pub2

2011-10 Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence PMID 21975742 https://doi.org/10.1002/14651858.CD004147.pub4

2011-9 Universal family-based prevention programs for alcohol misuse in young people PMID 21901733 https://doi.org/10.1002/14651858.CD009308

2011-9 Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification PMID 21901695 https://doi.org/10.1002/14651858.CD005031.pub4

2011-8 Brief interventions for heavy alcohol users admitted to general hospital wards PMID 21833953 https://doi.org/10.1002/14651858.CD005191.pub3

2011-8 Oral substitution treatment of injecting opioid users for prevention of HIV infection PMID 21833948 https://doi.org/10.1002/14651858.CD004145.pub4

2011-5 Universal school-based prevention programs for alcohol misuse in young people PMID 21563171 https://doi.org/10.1002/14651858.CD009113

2011-5 Motivational interviewing for substance abuse PMID 21563163 https://doi.org/10.1002/14651858.CD008063.pub2

Epilepsy Group
Updated: Aug 1 2023

2023-4 Perampanel add-on for drug-resistant focal epilepsy PMID 37059702 https://doi.org/10.1002/14651858.CD010961.pub2

2023-1 Prognosis of adults and children following a first unprovoked seizure PMID 36688481 https://doi.org/10.1002/14651858.CD013847.pub2

2022-8 Felbamate add-on therapy for drug-resistant focal epilepsy PMID 35914010 https://doi.org/10.1002/14651858.CD008295.pub6

2022-7 Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy PMID 35844168 https://doi.org/10.1002/14651858.CD013136.pub2

2022-4 Care delivery and self-management strategies for children with epilepsy PMID undefined https://doi.org/10.1002/14651858.CD006245.pub5

2022-2 Clonazepam monotherapy for treating people with newly diagnosed epilepsy PMID undefined https://doi.org/10.1002/14651858.CD013028.pub3

2022-1 Rapid versus slow withdrawal of antiepileptic drugs PMID undefined https://doi.org/10.1002/14651858.CD005003.pub4

2021-12 Carisbamate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD012121.pub2

2021-11 Topiramate for juvenile myoclonic epilepsy PMID undefined https://doi.org/10.1002/14651858.CD010008.pub5

2021-9 Sulthiame monotherapy for epilepsy PMID undefined https://doi.org/10.1002/14651858.CD010062.pub3

2021-8 Chloral hydrate as a sedating agent for neurodiagnostic procedures in children PMID undefined https://doi.org/10.1002/14651858.CD011786.pub3

2021-6 Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008907.pub4

2021-5 Treatment of epilepsy for people with Alzheimer's disease PMID undefined https://doi.org/10.1002/14651858.CD011922.pub4

2021-5 Lacosamide add-on therapy for focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008841.pub3

2021-5 Medications for daytime sleepiness in individuals with idiopathic hypersomnia PMID undefined https://doi.org/10.1002/14651858.CD012714.pub2

2021-4 Antidepressants for people with epilepsy and depression PMID undefined https://doi.org/10.1002/14651858.CD010682.pub3

2021-4 Transcranial magnetic stimulation for the treatment of epilepsy PMID undefined https://doi.org/10.1002/14651858.CD011025.pub3

2021-1 Gabapentin add-on treatment for drug-resistant focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD001415.pub4

2020-11 Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner Syndrome PMID undefined https://doi.org/10.1002/14651858.CD013132.pub2

2020-11 Rufinamide add-on therapy for drug-resistant epilepsy PMID undefined https://doi.org/10.1002/14651858.CD011772.pub3

2020-10 Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy PMID undefined https://doi.org/10.1002/14651858.CD008312.pub4

2020-7 Zonisamide add-on therapy for focal epilepsy PMID undefined https://doi.org/10.1002/14651858.CD001416.pub5

2019-12 Losigamone add-on therapy for focal epilepsy PMID 31823350 https://doi.org/10.1002/14651858.CD009324.pub5

2019-12 Intravenous immunoglobulins for epilepsy PMID 31792946 https://doi.org/10.1002/14651858.CD008557.pub4

2019-10 Tiagabine add-on therapy for drug-resistant focal epilepsy PMID 31608990 https://doi.org/10.1002/14651858.CD001908.pub4

2019-10 Clobazam add-on therapy for drug-resistant epilepsy PMID 31638272 https://doi.org/10.1002/14651858.CD004154.pub5

2019-10 Topiramate add-on therapy for drug-resistant focal epilepsy PMID 31642054 https://doi.org/10.1002/14651858.CD001417.pub4

2019-8 Sulthiame add-on therapy for epilepsy PMID 31453633 https://doi.org/10.1002/14651858.CD009472.pub4

2019-6 Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 31233229 https://doi.org/10.1002/14651858.CD012065.pub3

2019-6 Surgery for epilepsy PMID 31237346 https://doi.org/10.1002/14651858.CD010541.pub3

2018-11 Subpial transection surgery for epilepsy PMID 30383287 https://doi.org/10.1002/14651858.CD008153.pub4

2018-10 Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review PMID 30350354 https://doi.org/10.1002/14651858.CD003615.pub4

2018-6 Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review PMID 29952431 https://doi.org/10.1002/14651858.CD001031.pub4

2017-10 The role of high-frequency oscillations in epilepsy surgery planning PMID 28981957 https://doi.org/10.1002/14651858.CD010235.pub3

2017-7 Deep brain and cortical stimulation for epilepsy PMID 28718878 https://doi.org/10.1002/14651858.CD008497.pub3

2017-2 Propofol versus thiopental sodium for the treatment of refractory status epilepticus PMID 28155226 https://doi.org/10.1002/14651858.CD009202.pub4

2016-8 Polyunsaturated fatty acid supplementation for drug-resistant epilepsy PMID 27536971 https://doi.org/10.1002/14651858.CD011014.pub2

2016-5 Antiepileptic drugs for the primary and secondary prevention of seizures in viral encephalitis PMID 27209627 https://doi.org/10.1002/14651858.CD010247.pub3

2016-2 Care delivery and self management strategies for adults with epilepsy PMID 26842929 https://doi.org/10.1002/14651858.CD006244.pub3

2015-12 Interventions for psychotic symptoms concomitant with epilepsy PMID 26690687 https://doi.org/10.1002/14651858.CD006118.pub3

2015-11 Vigabatrin versus carbamazepine monotherapy for epilepsy PMID 26580100 https://doi.org/10.1002/14651858.CD008781.pub3

2015-9 Non-pharmacological interventions for people with epilepsy and intellectual disabilities PMID 26355236 https://doi.org/10.1002/14651858.CD005502.pub3

2015-9 Pharmacological interventions for epilepsy in people with intellectual disabilities PMID 26333428 https://doi.org/10.1002/14651858.CD005399.pub3

2015-8 Pharmacological treatments for preventing epilepsy following traumatic head injury PMID 26259048 https://doi.org/10.1002/14651858.CD009900.pub2

2015-7 Neuropsychological and psychological interventions for people with newly diagnosed epilepsy PMID 26198593 https://doi.org/10.1002/14651858.CD011311.pub2

2015-6 Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms PMID 26086765 https://doi.org/10.1002/14651858.CD005222.pub3

2015-2 Early versus late antiepileptic drug withdrawal for people with epilepsy in remission PMID 25922863 https://doi.org/10.1002/14651858.CD001902.pub2

2014-9 Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes PMID 25190506 https://doi.org/10.1002/14651858.CD006779.pub2

2014-2 Psychological and behavioural treatments for adults with non-epileptic attack disorder PMID 24519702 https://doi.org/10.1002/14651858.CD006370.pub2

2013-6 Treatment of infantile spasms PMID 23740534 https://doi.org/10.1002/14651858.CD001770.pub3

2011-8 Antiepileptic drugs for treating seizures in adults with brain tumours PMID 21833969 https://doi.org/10.1002/14651858.CD008586.pub2

Movement Disorders Group
Updated: Aug 1 2023

✅ 2023-1 Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis PMID 36602886 https://doi.org/10.1002/14651858.CD013856.pub2

2022-6 Interventions for preventing falls in Parkinson's disease PMID 35665915 https://doi.org/10.1002/14651858.CD011574.pub2

2021-4 Botulinum toxin type A versus anticholinergics for cervical dystonia PMID undefined https://doi.org/10.1002/14651858.CD004312.pub3

2020-7 GLP-1 receptor agonists for Parkinson's disease PMID undefined https://doi.org/10.1002/14651858.CD012990.pub2

2016-10 Botulinum toxin type A versus botulinum toxin type B for cervical dystonia PMID 27782297 https://doi.org/10.1002/14651858.CD004314.pub3

2016-7 Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease PMID 27425786 https://doi.org/10.1002/14651858.CD010916.pub2

2016-7 Speech therapy for children with dysarthria acquired before three years of age PMID 27428115 https://doi.org/10.1002/14651858.CD006937.pub3

2015-12 Alprazolam for essential tremor PMID 26638213 https://doi.org/10.1002/14651858.CD009681.pub2

2015-9 Treadmill training for patients with Parkinson's disease PMID 26363646 https://doi.org/10.1002/14651858.CD007830.pub4

2014-6 Physiotherapy for Parkinson's disease: a comparison of techniques PMID 24936965 https://doi.org/10.1002/14651858.CD002815.pub2

2013-9 Botulinum toxin for masseter hypertrophy PMID 24018587 https://doi.org/10.1002/14651858.CD007510.pub3

2012-8 Comparison of speech and language therapy techniques for speech problems in Parkinson's disease PMID 22895931 https://doi.org/10.1002/14651858.CD002814.pub2

2012-8 Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease PMID 22895930 https://doi.org/10.1002/14651858.CD002812.pub2

2011-11 Helicobacter pylori eradication for Parkinson's disease PMID 22071847 https://doi.org/10.1002/14651858.CD008453.pub2

2011-11 Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials PMID 22071852 https://doi.org/10.1002/14651858.CD008535.pub2

2011-11 Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies PMID 22071848 https://doi.org/10.1002/14651858.CD008454.pub2

Multiple Sclerosis and Rare Diseases of the CNS Group
Updated: Aug 1 2023

2023-6 Alemtuzumab for multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD011203.pub3

✅ 2022-5 Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD013444.pub2

2021-11 Rituximab for people with multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD013874.pub2

2021-11 Siponimod for multiple sclerosis PMID undefined https://doi.org/10.1002/14651858.CD013647.pub2

Neuromuscular Group
Updated: Aug 1 2023

2023-2 Local corticosteroid injection versus placebo for carpal tunnel syndrome PMID 36722795 https://doi.org/10.1002/14651858.CD015148

2023-2 Methods for informing people with amyotrophic lateral sclerosis/motor neuron disease of their diagnosis PMID 36812393 https://doi.org/10.1002/14651858.CD007593.pub2

2023-2 Splinting for carpal tunnel syndrome PMID 36848651 https://doi.org/10.1002/14651858.CD010003.pub2

2022-12 Bioengineered nerve conduits and wraps for peripheral nerve repair of the upper limb PMID 36477774 https://doi.org/10.1002/14651858.CD012574.pub2

2022-1 Immunoglobulin for multifocal motor neuropathy PMID undefined https://doi.org/10.1002/14651858.CD004429.pub3

2021-12 Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline PMID undefined https://doi.org/10.1002/14651858.CD013720.pub3

2021-5 Non-drug therapies for the secondary prevention of lower limb muscle cramps PMID undefined https://doi.org/10.1002/14651858.CD008496.pub3

2021-5 Fludrocortisone for orthostatic hypotension PMID undefined https://doi.org/10.1002/14651858.CD012868.pub2

2021-5 Interventions for promoting physical activity in people with neuromuscular disease PMID undefined https://doi.org/10.1002/14651858.CD013544.pub2

2021-4 Cough augmentation techniques for people with chronic neuromuscular disorders PMID undefined https://doi.org/10.1002/14651858.CD013170.pub2

2020-1 Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome PMID undefined https://doi.org/10.1002/14651858.CD008630.pub5

2019-9 Respiratory muscle training in children and adults with neuromuscular disease PMID 31487757 https://doi.org/10.1002/14651858.CD011711.pub2

2019-3 Physical exercise training for type 3 spinal muscular atrophy PMID 30821348 https://doi.org/10.1002/14651858.CD012120.pub2

2018-12 Acupuncture for symptomatic gastroparesis PMID 30560568 https://doi.org/10.1002/14651858.CD009676.pub2

2018-10 Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy PMID 30326162 https://doi.org/10.1002/14651858.CD009068.pub3

2018-1 Treatment of fatigue in amyotrophic lateral sclerosis/motor neuron disease PMID 29293261 https://doi.org/10.1002/14651858.CD011005.pub2

2017-12 Invasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disorders PMID 29199768 https://doi.org/10.1002/14651858.CD008380.pub2

2017-11 Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy PMID 29185258 https://doi.org/10.1002/14651858.CD002062.pub4

2017-8 Low-level laser therapy for carpal tunnel syndrome PMID 35611937 https://doi.org/10.1002/14651858.CD012765

2017-7 Immunotherapy for diabetic amyotrophy PMID 28746752 https://doi.org/10.1002/14651858.CD006521.pub4

2017-6 Drug therapy for chronic idiopathic axonal polyneuropathy PMID 28631805 https://doi.org/10.1002/14651858.CD003456.pub3

2017-5 Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 28481421 https://doi.org/10.1002/14651858.CD003280.pub5

2017-2 Plasma exchange for Guillain-Barré syndrome PMID 28241090 https://doi.org/10.1002/14651858.CD001798.pub3

2017-1 Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease PMID 28072907 https://doi.org/10.1002/14651858.CD011776.pub2

2017-1 Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease PMID 28067943 https://doi.org/10.1002/14651858.CD006049.pub2

2016-12 Antibiotics for the neurological complications of Lyme disease PMID 27931077 https://doi.org/10.1002/14651858.CD006978.pub2

2016-10 Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies PMID 27701752 https://doi.org/10.1002/14651858.CD002827.pub4

2016-8 Pharmacological treatments for Friedreich ataxia PMID 27572719 https://doi.org/10.1002/14651858.CD007791.pub4

2016-5 Corticosteroids for treating nerve damage in leprosy PMID 27210895 https://doi.org/10.1002/14651858.CD005491.pub3

2016-2 Rehabilitation following carpal tunnel release PMID 26884379 https://doi.org/10.1002/14651858.CD004158.pub3

2016-2 Interventions for dysphagia in long-term, progressive muscle disease PMID 26859621 https://doi.org/10.1002/14651858.CD004303.pub4

2015-12 Ascorbic acid for the treatment of Charcot-Marie-Tooth disease PMID 26662471 https://doi.org/10.1002/14651858.CD011952

2015-10 Surgery for scoliosis in Duchenne muscular dystrophy PMID 26423318 https://doi.org/10.1002/14651858.CD005375.pub4

2015-8 Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy PMID 26305459 https://doi.org/10.1002/14651858.CD003906.pub4

2015-6 Treatment for inclusion body myositis PMID 35658164 https://doi.org/10.1002/14651858.CD001555.pub5

2015-4 Quinine for muscle cramps PMID 25842375 https://doi.org/10.1002/14651858.CD005044.pub3

2015-3 Treatment for IgG and IgA paraproteinaemic neuropathy PMID 25803231 https://doi.org/10.1002/14651858.CD005376.pub3

2015-3 Physical rehabilitation for critical illness myopathy and neuropathy PMID 25737049 https://doi.org/10.1002/14651858.CD010942.pub2

2015-3 Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy PMID 25739040 https://doi.org/10.1002/14651858.CD003217.pub5

2014-12 Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders PMID 25503955 https://doi.org/10.1002/14651858.CD001941.pub3

2014-12 Interventions for fatigue in peripheral neuropathy PMID 25519471 https://doi.org/10.1002/14651858.CD008146.pub2

2014-12 Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection PMID 25525951 https://doi.org/10.1002/14651858.CD010404.pub2

2014-11 Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V) PMID 25391139 https://doi.org/10.1002/14651858.CD003458.pub5

2014-3 Interventions for preventing neuropathy caused by cisplatin and related compounds PMID 24687190 https://doi.org/10.1002/14651858.CD005228.pub4

2014-1 Interventions for preventing critical illness polyneuropathy and critical illness myopathy PMID 24477672 https://doi.org/10.1002/14651858.CD006832.pub3

2014-1 Endoscopic release for carpal tunnel syndrome PMID 24482073 https://doi.org/10.1002/14651858.CD008265.pub2

2013-12 Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy PMID 24379104 https://doi.org/10.1002/14651858.CD001797.pub3

2013-12 Immunotherapy for idiopathic lumbosacral plexopathy PMID 24379134 https://doi.org/10.1002/14651858.CD009722.pub2

2013-12 Mechanical insufflation-exsufflation for people with neuromuscular disorders PMID 24374746 https://doi.org/10.1002/14651858.CD010044.pub2

2013-12 Non-antiepileptic drugs for trigeminal neuralgia PMID 24297506 https://doi.org/10.1002/14651858.CD004029.pub4

2013-10 Chinese herbal medicine for diabetic peripheral neuropathy PMID 24096743 https://doi.org/10.1002/14651858.CD007796.pub3

2013-6 Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease PMID 23740607 https://doi.org/10.1002/14651858.CD005226.pub3

2013-5 Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease PMID 23728653 https://doi.org/10.1002/14651858.CD005229.pub3

2013-3 Therapeutic ultrasound for carpal tunnel syndrome PMID 23543580 https://doi.org/10.1002/14651858.CD009601.pub2

2012-12 Treatment for meralgia paraesthetica PMID 23235604 https://doi.org/10.1002/14651858.CD004159.pub3

2012-12 Treatment for paraneoplastic neuropathies PMID 23235647 https://doi.org/10.1002/14651858.CD007625.pub2

2012-12 Medical and surgical treatment for ocular myasthenia PMID 23235620 https://doi.org/10.1002/14651858.CD005081.pub3

2012-12 Decompressive surgery for treating nerve damage in leprosy PMID 23235638 https://doi.org/10.1002/14651858.CD006983.pub3

2012-12 Intravenous immunoglobulin for myasthenia gravis PMID 23235588 https://doi.org/10.1002/14651858.CD002277.pub4

2012-11 Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease PMID 23152212 https://doi.org/10.1002/14651858.CD002064.pub3

2012-8 Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis PMID 22895935 https://doi.org/10.1002/14651858.CD003643.pub4

2012-6 Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome PMID 22696361 https://doi.org/10.1002/14651858.CD006828.pub3

2012-6 Exercise and mobilisation interventions for carpal tunnel syndrome PMID 22696387 https://doi.org/10.1002/14651858.CD009899

2012-4 Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease PMID 22513921 https://doi.org/10.1002/14651858.CD004157.pub2

2012-2 Treatment for spasticity in amyotrophic lateral sclerosis/motor neuron disease PMID 22336799 https://doi.org/10.1002/14651858.CD004156.pub4

2011-12 Physical training for McArdle disease PMID 22161416 https://doi.org/10.1002/14651858.CD007931.pub2

SEED Project Links
Schmidt et al 2017, Syst Rev: SEED: a tool for disseminating systematic review data into Wikipedia
 * SEED tool home page: https://schizophrenia.cochrane.org/resources/resources-authors/systematic-evidence-dissemination-seed
 * RCT protocol (ended August 2018) looking at impact of SEED: The effects of Wikipedia referencing: a protocol for a randomised trial.

Schizophrenia Group
Updated: Aug 1 2023

2023-7 Cognitive behavioural therapy plus standard care versus standard care for persistent aggressive behaviour or agitation in people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD013511.pub2

2023-6 Magnetic seizure therapy for people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD012697.pub2

2022-11 Antipsychotic dose reduction compared to dose continuation for people with schizophrenia PMID 36420692 https://doi.org/10.1002/14651858.CD014384.pub2

2022-10 Pharmacological interventions for prevention of weight gain in people with schizophrenia PMID 36190739 https://doi.org/10.1002/14651858.CD013337.pub2

2022-8 Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia PMID 36042158 https://doi.org/10.1002/14651858.CD014383.pub2

2022-7 Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms PMID 35844143 https://doi.org/10.1002/14651858.CD013100.pub2

2022-7 Cognitive behavioural therapy (group) for schizophrenia PMID 35866377 https://doi.org/10.1002/14651858.CD009608.pub2

2021-10 Parenting interventions for people with schizophrenia or related serious mental illness PMID undefined https://doi.org/10.1002/14651858.CD013536.pub2

2021-2 Video games for people with schizophrenia PMID undefined https://doi.org/10.1002/14651858.CD012844.pub2

2020-11 Specialised early intervention teams for recent-onset psychosis PMID undefined https://doi.org/10.1002/14651858.CD013288.pub2

2020-11 Specialised early intervention teams (extended time) for recent-onset psychosis PMID undefined https://doi.org/10.1002/14651858.CD013287.pub2

2019-8 Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses PMID 31425609 https://doi.org/10.1002/14651858.CD006570.pub3

2019-4 Haloperidol discontinuation for people with schizophrenia PMID 31006114 https://doi.org/10.1002/14651858.CD011408.pub2

2019-4 Yoga as part of a package of care versus non-standard care for schizophrenia PMID 30990224 https://doi.org/10.1002/14651858.CD012807.pub2

2018-10 Chlorpromazine versus piperacetazine for schizophrenia PMID 30378678 https://doi.org/10.1002/14651858.CD011709.pub2

2018-10 Occupational therapy delivered by specialists versus non-specialists for people with schizophrenia PMID 30293234 https://doi.org/10.1002/14651858.CD012398.pub2

2018-5 Increasing antipsychotic dose for non response in schizophrenia PMID 29750432 https://doi.org/10.1002/14651858.CD011883.pub2

2018-4 Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29634083 https://doi.org/10.1002/14651858.CD009412.pub2

2018-3 Miscellaneous treatments for antipsychotic-induced tardive dyskinesia PMID 29552749 https://doi.org/10.1002/14651858.CD000208.pub2

2018-3 Cholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29553158 https://doi.org/10.1002/14651858.CD000207.pub2

2018-2 Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia PMID 29409162 https://doi.org/10.1002/14651858.CD000459.pub3

2018-1 Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia PMID 29342497 https://doi.org/10.1002/14651858.CD000458.pub3

2018-1 Aripiprazole (intramuscular) for psychosis-induced aggression or agitation (rapid tranquillisation) PMID 29308601 https://doi.org/10.1002/14651858.CD008074.pub2

2018-1 Anticholinergic medication for antipsychotic-induced tardive dyskinesia PMID 29341071 https://doi.org/10.1002/14651858.CD000204.pub2

2018-1 Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse PMID 29355909 https://doi.org/10.1002/14651858.CD011057.pub2

2017-10 Different communication strategies for disclosing a diagnosis of schizophrenia and related disorders PMID 29064090 https://doi.org/10.1002/14651858.CD011707.pub2

2017-9 Chlorpromazine versus penfluridol for schizophrenia PMID 28940256 https://doi.org/10.1002/14651858.CD011831.pub2

2017-9 Yoga as part of a package of care versus standard care for schizophrenia PMID 28960019 https://doi.org/10.1002/14651858.CD012145.pub2

2017-6 Communication skills training for mental health professionals working with people with severe mental illness PMID 28613384 https://doi.org/10.1002/14651858.CD010006.pub2

2017-6 Clozapine dose for schizophrenia PMID 28613395 https://doi.org/10.1002/14651858.CD009555.pub2

2017-4 Chlorpromazine versus clotiapine for schizophrenia PMID 28387925 https://doi.org/10.1002/14651858.CD011810.pub2

2017-4 De-escalation techniques for psychosis-induced aggression or agitation PMID 28368091 https://doi.org/10.1002/14651858.CD009922.pub2

2017-4 Chlorpromazine dose for people with schizophrenia PMID 28407198 https://doi.org/10.1002/14651858.CD007778.pub2

2017-3 Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia PMID 28333365 https://doi.org/10.1002/14651858.CD006324.pub3

2017-1 Psychological interventions for post-traumatic stress disorder (PTSD) in people with severe mental illness PMID 28116752 https://doi.org/10.1002/14651858.CD011464.pub2

2016-12 Droperidol for psychosis-induced aggression or agitation PMID 27976370 https://doi.org/10.1002/14651858.CD002830.pub3

2016-12 Implementation of treatment guidelines for specialist mental health care PMID 27977851 https://doi.org/10.1002/14651858.CD009780.pub3

2016-11 Haloperidol for long-term aggression in psychosis PMID 27889922 https://doi.org/10.1002/14651858.CD009830.pub2

2016-10 Bifeprunox versus placebo for schizophrenia PMID 27732740 https://doi.org/10.1002/14651858.CD012029.pub2

2016-9 HIV prevention advice for people with serious mental illness PMID 27609030 https://doi.org/10.1002/14651858.CD009639.pub3

2016-9 Oral health education (advice and training) for people with serious mental illness PMID 27606629 https://doi.org/10.1002/14651858.CD008802.pub3

2016-9 Interventions to encourage uptake of cancer screening for people with severe mental illness PMID 27668891 https://doi.org/10.1002/14651858.CD009641.pub3

2016-7 Fluphenazine (oral) versus atypical antipsychotics for schizophrenia PMID 27370402 https://doi.org/10.1002/14651858.CD010832.pub2

2016-6 Pharmacological interventions for clozapine-induced sinus tachycardia PMID 27277334 https://doi.org/10.1002/14651858.CD011566.pub2

2016-4 Chlorpromazine versus atypical antipsychotic drugs for schizophrenia PMID 27045703 https://doi.org/10.1002/14651858.CD010631.pub2

2016-4 Risperidone (depot) for schizophrenia PMID 27078222 https://doi.org/10.1002/14651858.CD004161.pub2

2016-3 Dietary advice for people with schizophrenia PMID 27007216 https://doi.org/10.1002/14651858.CD009547.pub2

2016-2 Antioxidant treatments for schizophrenia PMID 26848926 https://doi.org/10.1002/14651858.CD008919.pub2

2016-1 Antiglucocorticoid and related treatments for psychosis PMID 26725721 https://doi.org/10.1002/14651858.CD006995.pub2

2016-1 Smoking cessation advice for people with serious mental illness PMID 26816385 https://doi.org/10.1002/14651858.CD009704.pub2

2015-12 'As required' medication regimens for seriously mentally ill people in hospital PMID 26689942 https://doi.org/10.1002/14651858.CD003441.pub3

2015-12 Crisis intervention for people with severe mental illnesses PMID 26633650 https://doi.org/10.1002/14651858.CD001087.pub5

2015-12 Zuclopenthixol versus placebo for schizophrenia PMID 26624987 https://doi.org/10.1002/14651858.CD010598.pub2

2015-10 Cognitive behavioural therapy (brief versus standard duration) for schizophrenia PMID 26488686 https://doi.org/10.1002/14651858.CD010646.pub3

2015-10 Yoga versus standard care for schizophrenia PMID 26488850 https://doi.org/10.1002/14651858.CD010554.pub2

2015-10 Lithium for schizophrenia PMID 26509923 https://doi.org/10.1002/14651858.CD003834.pub3

2015-8 Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis PMID 26252640 https://doi.org/10.1002/14651858.CD011021.pub2

2015-6 Social skills programmes for schizophrenia PMID 26059249 https://doi.org/10.1002/14651858.CD009006.pub2

2015-5 Psychoeducation for siblings of people with severe mental illness PMID 25953641 https://doi.org/10.1002/14651858.CD010540.pub2

2015-2 Fluphenazine decanoate (depot) and enanthate for schizophrenia PMID 25654768 https://doi.org/10.1002/14651858.CD000307.pub2

2015-1 Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders PMID 25592299 https://doi.org/10.1002/14651858.CD009831.pub2

2014-10 Virtual reality for treatment compliance for people with serious mental illness PMID 25300174 https://doi.org/10.1002/14651858.CD009928.pub2

2014-10 Perphenazine versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25290157 https://doi.org/10.1002/14651858.CD009369.pub2

2014-9 Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25177834 https://doi.org/10.1002/14651858.CD009227.pub2

2014-7 Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia PMID 25007358 https://doi.org/10.1002/14651858.CD009268.pub2

2014-6 Information and communication technology based prompting for treatment compliance for people with serious mental illness PMID 24934254 https://doi.org/10.1002/14651858.CD009960.pub2

2014-6 Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders PMID 24915451 https://doi.org/10.1002/14651858.CD001470.pub2

2014-5 Horticultural therapy for schizophrenia PMID 24842458 https://doi.org/10.1002/14651858.CD009413.pub2

2014-3 General physical health advice for people with serious mental illness PMID 24676557 https://doi.org/10.1002/14651858.CD008567.pub3

2014-3 Family intervention (brief) for schizophrenia PMID 24595545 https://doi.org/10.1002/14651858.CD009802.pub2

2014-1 Length of hospitalisation for people with severe mental illness PMID 24477710 https://doi.org/10.1002/14651858.CD000384.pub3

2014-1 Physical health care monitoring for people with serious mental illness PMID 24442580 https://doi.org/10.1002/14651858.CD008298.pub3

2013-12 Anticholinergic medication for non-clozapine neuroleptic-induced hypersalivation in people with schizophrenia PMID 24353163 https://doi.org/10.1002/14651858.CD009546.pub2

2013-11 Collaborative care approaches for people with severe mental illness PMID 24190251 https://doi.org/10.1002/14651858.CD009531.pub2

2013-10 User-held personalised information for routine care of people with severe mental illness PMID 24096715 https://doi.org/10.1002/14651858.CD001711.pub2

2013-10 Dance therapy for schizophrenia PMID 24092546 https://doi.org/10.1002/14651858.CD006868.pub3

2013-8 Haloperidol dose for the acute phase of schizophrenia PMID 23983042 https://doi.org/10.1002/14651858.CD001951.pub2

2013-7 Intermittent drug techniques for schizophrenia PMID 23881657 https://doi.org/10.1002/14651858.CD006196.pub2

2013-6 Preventive interventions for postnatal psychosis PMID 23740790 https://doi.org/10.1002/14651858.CD009991.pub2

2013-2 Training to recognise the early signs of recurrence in schizophrenia PMID 23450559 https://doi.org/10.1002/14651858.CD005147.pub2

2012-11 Management of sexual dysfunction due to antipsychotic drug therapy PMID 23152218 https://doi.org/10.1002/14651858.CD003546.pub3

2012-11 Bromperidol decanoate (depot) for schizophrenia PMID 23152208 https://doi.org/10.1002/14651858.CD001719.pub4

2012-10 Information and communication technology in patient education and support for people with schizophrenia PMID 23076932 https://doi.org/10.1002/14651858.CD007198.pub2

2012-6 Paliperidone palmitate for schizophrenia PMID 22696377 https://doi.org/10.1002/14651858.CD008296.pub2

2012-4 Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses PMID 22513898 https://doi.org/10.1002/14651858.CD000525.pub3

2012-2 Antipsychotic drug treatment for elderly people with late-onset schizophrenia PMID 22336800 https://doi.org/10.1002/14651858.CD004162.pub2

2011-12 Day hospital versus admission for acute psychiatric disorders PMID 22161384 https://doi.org/10.1002/14651858.CD004026.pub2

2011-6 Psychoeducation for schizophrenia PMID 21678337 https://doi.org/10.1002/14651858.CD002831.pub2

2011-6 Antipsychotic medication for early episode schizophrenia PMID 21678355 https://doi.org/10.1002/14651858.CD006374.pub2